KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Prepaid Assets (2016 - 2025)

Ionis Pharmaceuticals has reported Prepaid Assets over the past 17 years, most recently at $237.1 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $237.1 million for Q4 2025, up 8.79% from a year ago — trailing twelve months through Dec 2025 was $237.1 million (up 8.79% YoY), and the annual figure for FY2025 was $237.1 million, up 8.79%.
  • Prepaid Assets for Q4 2025 was $237.1 million at Ionis Pharmaceuticals, down from $243.7 million in the prior quarter.
  • Over the last five years, Prepaid Assets for IONS hit a ceiling of $243.7 million in Q3 2025 and a floor of $123.8 million in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $176.0 million (2023), compared with a mean of $178.2 million.
  • Biggest five-year swings in Prepaid Assets: dropped 6.81% in 2021 and later skyrocketed 32.33% in 2025.
  • Ionis Pharmaceuticals' Prepaid Assets stood at $143.4 million in 2021, then rose by 17.35% to $168.3 million in 2022, then increased by 22.1% to $205.4 million in 2023, then grew by 6.09% to $217.9 million in 2024, then increased by 8.79% to $237.1 million in 2025.
  • The last three reported values for Prepaid Assets were $237.1 million (Q4 2025), $243.7 million (Q3 2025), and $226.1 million (Q2 2025) per Business Quant data.